The American Journal of Surgery
Volume 170, Issue 2 , Pages 126-130, August 1995

In vivo platelet deposition on polytetrafluoroethylene coated with fibrin glue containing fibroblast growth factor 1 and heparin in a canine model☆☆

  • Claire Gosselin, MD

      Affiliations

    • Department of Surgery, Loyola University Medical Center, Maywood, Illinois, USA
  • ,
  • Dewei Ren, MD

      Affiliations

    • Department of Surgery, Loyola University Medical Center, Maywood, Illinois, USA
  • ,
  • Joan Ellinger

      Affiliations

    • Department of Surgery Hines VA Hospital, Hines, Illinois, USA
  • ,
  • Howard P. Greisler, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Howard P. Greisler, MD, Loyola University Medical Center, Department of Surgery, 2160 South First Avenue, Maywood, Illinois 60153.
    • Department of Surgery, Loyola University Medical Center, Maywood, Illinois, USA
    • Department of Cell Biology, Neurobiology and Anatomy, Loyola University Medical Center, Maywood, Illinois, USA
    • Department of Surgery Hines VA Hospital, Hines, Illinois, USA

Abstract 

Background: We previously reported that the coating of expanded polytetrafluoroethylene (ePTFE) with fibrin glue containing fibroblast growth factor 1 (FGF-1) and heparin accelerates endothelial coverage of grafts implanted into animals. We report here the effect of this surface modification on early platelet deposition.

Materials and methods: Nine dogs received 7-cm ePTFE grafts, 60-μm internodal distance, 4-mm internal diameter, as bilateral aortoiliac implants, one coated (luminal cross section and abluminal surface) with fibrin glue (fibrinogen 32.1 mg/mL, thrombin 0.32 U/mL) containing FGF-1 (11 ng/mL) and heparin (250 U/mL), the other uncoated. After 5, 30, or 120 minutes of circulation with blood containing autologous platelets radiolabeled with indium 111, γ emissions were quantitated on explants and correlated to surface areas measured by computerized planimetry.

Results: Both global and segmental comparisons showed significantly (P <0.05, Student's t-test) less platelet deposition on coated than on uncoated grafts after 120 minutes of circulation, but no difference at 5 and 30 minutes.

Conclusions: In this model, ePTFE coating with fibrin glue containing FGF-1 and heparin shows no adverse effect on early platelet deposition.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by grant RO1 HL41272 from the National Institutes of Health.Dr. Gosselin is supported by a grant from the R. Samuel McLaughlin Foundation, Toronto, Canada.

☆☆ Presented at the 23rd Annual Meeting of The Society for Clinical Vascular Surgery, Fort Lauderdale, Florida, March 22–26, 1995.

PII: S0002-9610(99)80270-0

The American Journal of Surgery
Volume 170, Issue 2 , Pages 126-130, August 1995